Literature DB >> 14960188

Signaling role of iron in NF-kappa B activation in hepatic macrophages.

Shigang Xiong1, Hongyun She, Hidekazu Tsukamoto.   

Abstract

Iron is both essential and toxic for cells and impaired iron homeostasis has been shown to cause or potentiate various forms of liver injury. Research in our laboratory suggests that iron also plays a pivotal role in intracellular signaling for NF-kappa B activation in hepatic macrophages (HM). Our results showed: 1) HM from alcohol-fed rats had a increase in the nonheme iron content accompanied by NF-kappa B activation; 2) iron chelation normalized nonheme iron concentration and blocked enhanced NF-kappa B activation and TNF-alpha expression in these cells; 3) LPS-induced NF-kappa B activation was also blocked by iron chelator; 4) iron directly induced TNF-alpha expression via IKK and NF-kappa B activation in normal HM. We propose that iron acts as an independent proinflammatory molecule via induction of the intracellular signaling for NF-kappa B activation in HM and primes the liver for chronic inflammation and injury.

Entities:  

Year:  2004        PMID: 14960188      PMCID: PMC2410254          DOI: 10.1186/1476-5926-2-S1-S36

Source DB:  PubMed          Journal:  Comp Hepatol        ISSN: 1476-5926


Iron and HM NF-kappa B activation in alcohol model

Our earlier study showed that hepatic macrophages (HM) from rats fed ethanol and high fat diet had a significant 70% increase in the nonheme iron content as compared to controls [1]. This study also suggested enhanced heme turnover as a cause of the increased iron storage in HM. To test this notion, an increase in HM iron content was recapitulated in vitro by phagocytosis of heat-treated autologous red blood cells. To extend this observation to the whole animal situation, the effects of splenectomy on alcohol-fed animals were also examined. The most intriguing and critical finding from these cellular or animal model experimentations, was that activation of NF-kappa B was tightly correlated with the increased non-heme iron content in HM, suggesting the priming role of iron in NF-kappa B activation and proinflammatory cytokine expression by HM in alcoholic liver disease.

Direct iron induction of TNF-alpha in cultured HM

Direct addition of ferrous but not ferric iron in cultured HM increased TNF-alpha release 8 fold at 10 and 50 micromolar during a 4 hr treatment period without cell toxicity. Cuprous (Cu1+) but not cupric (Cu2+) copper also stimulated TNF-alpha release at 50 micromolar to less extent. Thus, these results demonstrate direct stimulation of HM TNF-alpha release by iron and copper in a redox status dependent manner. We then tested whether Fe2+ stimulates TNF-alpha promoter in cultured HM. The promoter activity was indeed increased 2~3 fold with 10~50 micromolar Fe2+. Cu1+ (50 micromolar) also slightly increased TNF-alpha promoter activity but not Cu2+ or Fe3+ (Figure 1). Co-transfection of a super repressor I-kappa B-alpha vector completely abrogated the stimulation with 50 micromolar Fe2+ (Figure 1). The enhanced promoter activity with 50 micromolar Fe2+ was about half of the maximal response achieved with LPS (500 ng/ml) in a serum-free condition. These results establish that Fe2+ activates TNF-alpha promoter in a NF-kappa B dependent manner.
Figure 1

(A.) Cultured HM were transfected with a TNF-alpha promoter-lucigerase construct followed by the treatment with Fe2+, Fe3+, Cu1+ or Cu2+. The data were normalized by co-transfected Renilla luciferase activity. Note the Fe2+ induces the promoter activity by 2–3 fold at 10 and 50 micromolar. Cu1+ slightly induces but oxidized metals (Fe3+ and Cu2+) do not. (B.) HM were co-transfected with the promoter-luciferase construct with a vector of super-repressor I-kappa B-alpha (DN-I-kappa B), followed by addition of Fe2+. Note DN-I-kappa B completely blocks iron induced promoter activity.

(A.) Cultured HM were transfected with a TNF-alpha promoter-lucigerase construct followed by the treatment with Fe2+, Fe3+, Cu1+ or Cu2+. The data were normalized by co-transfected Renilla luciferase activity. Note the Fe2+ induces the promoter activity by 2–3 fold at 10 and 50 micromolar. Cu1+ slightly induces but oxidized metals (Fe3+ and Cu2+) do not. (B.) HM were co-transfected with the promoter-luciferase construct with a vector of super-repressor I-kappa B-alpha (DN-I-kappa B), followed by addition of Fe2+. Note DN-I-kappa B completely blocks iron induced promoter activity.

Iron-induced activation of IKK and NF-kappa B and ROS generation in cultured HM

As shown in the top panel of Figure 2, IKK activity, as assessed by phosphorylation of GST-I-kappa B-alpha, was increased at 15 min after addition of ferrous iron. The timing of IKK activation preceded a disappearance of cytosolic I-kappa B-alpha and an increase in the nuclear level of p65 at 30~45 min. Iron did not induce JNK and p38 activities (unpublished results). These results correlated well with induced NF-kappa B binding in iron-treated HM at 30 min and no effects on AP-1 binding in these cells (data not shown). Thus, these results unequivocally demonstrate that ferrous iron can directly and selectively stimulates the signaling leading to IKK and NF-kappa B activation in cultured HM. Addition of ferrous iron to these cells resulted in an enhancement of the hydroxyl and methyl-POBN adduct signals. Both signals increased with incubation time up to a maximum at 15–20 min, which coincided with IKK activation at 15~30 min and preceded activation of NF-kappa B at 30 min, suggesting the possible signaling role of the former in the latter events. In fact, this notion was made by previous studies which demonstrated activation of NF-kappa B by hydroxyl radical generating systems and a reversal of this effect by hydroxyl radical scavengers or metal chelators in Jurkat cells [2].
Figure 2

I-kappa B kinase (IKK) and c-Jun NH2-terminal kinase (JNK) activity were determined on HM lysate collected at different time points after FeSO4 treatment. Note that IKK activity as assessed by phosphoylation of GST-I-kappa B-alpha (P-I-kappa B-alpha), is increased at 15 min after addition of iron while no activation of JNK is evident.

I-kappa B kinase (IKK) and c-Jun NH2-terminal kinase (JNK) activity were determined on HM lysate collected at different time points after FeSO4 treatment. Note that IKK activity as assessed by phosphoylation of GST-I-kappa B-alpha (P-I-kappa B-alpha), is increased at 15 min after addition of iron while no activation of JNK is evident.

Discussion and Conclusion

Our studies to date strongly suggest the causal link between iron and activation of NF-kappa B in HM in both normal and alcohol-fed rats. These findings raise a question as to how iron signals to activate NF-kappa B. Since NF-kappa B is a redox sensitive transcription factor and ROS are implicated in its activation [3,4], it is reasonable to speculate that iron stimulates ROS production in HM and in turn ROS activates NF-kappa B. Conversely, stimulation of HM with an agonist such as LPS, induces ROS generation and ROS may initiate intracellular signaling that is dependent on a chelatable pool of iron. Nitric oxide (NO) is known to cause mobilization of intracellular iron [5] and to inhibit enzymes with catalytically active iron-sulfur groups [6]. Superoxide anion can also release iron from ferritin [7]. Indeed, our preliminary results demonstrate that a selective inhibitor of iNOS and Cu/Zn SOD overexpression abolish a LPS-mediated transient rise in the intracellular level of chelatable iron and NF-kappa B activation (unpublished observation). We propose that iron acts as a proinflammatory effector molecule via selective induction of the intracellular signaling for NF-kappa B activation and that dysregulation of this signaling mechanism may prime HM for chronic liver inflammation and injury.
  7 in total

1.  Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway.

Authors:  M T Anderson; F J Staal; C Gitler; L A Herzenberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

2.  Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells.

Authors:  J C Drapier; J B Hibbs
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

3.  The role of hydroxyl radical as a messenger in the activation of nuclear transcription factor NF-kappaB.

Authors:  X Shi; Z Dong; C Huang; W Ma; K Liu; J Ye; F Chen; S S Leonard; M Ding; V Castranova; V Vallyathan
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

4.  Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-kappa B.

Authors:  R Schreck; P A Baeuerle
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

5.  Induction of ferritin synthesis by oxidative stress. Transcriptional and post-transcriptional regulation by expansion of the "free" iron pool.

Authors:  G Cairo; L Tacchini; G Pogliaghi; E Anzon; A Tomasi; A Bernelli-Zazzera
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

6.  Iron primes hepatic macrophages for NF-kappaB activation in alcoholic liver injury.

Authors:  H Tsukamoto; M Lin; M Ohata; C Giulivi; S W French; G Brittenham
Journal:  Am J Physiol       Date:  1999-12

7.  Biosynthesis of nitric oxide activates iron regulatory factor in macrophages.

Authors:  J C Drapier; H Hirling; J Wietzerbin; P Kaldy; L C Kühn
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

  7 in total
  15 in total

1.  Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging.

Authors:  Emanuela Messa; Sonia Carturan; Chiara Maffè; Marisa Pautasso; Enrico Bracco; Antonella Roetto; Francesca Messa; Francesca Arruga; Ilaria Defilippi; Valentina Rosso; Chiara Zanone; Antonia Rotolo; Elisabetta Greco; Rosa M Pellegrino; Daniele Alberti; Giuseppe Saglio; Daniela Cilloni
Journal:  Haematologica       Date:  2010-06-09       Impact factor: 9.941

2.  Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.

Authors:  James E Nelson; Laura Wilson; Elizabeth M Brunt; Matthew M Yeh; David E Kleiner; Aynur Unalp-Arida; Kris V Kowdley
Journal:  Hepatology       Date:  2010-11-29       Impact factor: 17.425

Review 3.  Iron metabolism in Nonalcoholic Fatty Liver Disease.

Authors:  James E Nelson; Heather Klintworth; Kris V Kowdley
Journal:  Curr Gastroenterol Rep       Date:  2012-02

Review 4.  New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases.

Authors:  Jessica A Williams; Sharon Manley; Wen-Xing Ding
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

5.  Increased iron export by ferroportin induces restriction of HIV-1 infection in sickle cell disease.

Authors:  Namita Kumari; Tatiana Ammosova; Sharmin Diaz; Xionghao Lin; Xiaomei Niu; Andrey Ivanov; Marina Jerebtsova; Subhash Dhawan; Patricia Oneal; Sergei Nekhai
Journal:  Blood Adv       Date:  2016-12-27

Review 6.  Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease?

Authors:  Duygu Dee Harrison-Findik
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

7.  Role of cellular iron and oxygen in the regulation of HIV-1 infection.

Authors:  Sergei Nekhai; Namita Kumari; Subhash Dhawan
Journal:  Future Virol       Date:  2013-03       Impact factor: 1.831

Review 8.  Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis.

Authors:  Umbreen Ahmed; Patricia S Latham; Phillip S Oates
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

Review 9.  Protein Phosphatase-1 -targeted Small Molecules, Iron Chelators and Curcumin Analogs as HIV-1 Antivirals.

Authors:  Xionghao Lin; Tatyana Ammosova; Namita Kumari; Sergei Nekhai
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

10.  HIV-1 infection in sickle cell disease and sickle cell trait: role of iron and innate response.

Authors:  Sergei Nekhai; Namita Kumari
Journal:  Expert Rev Hematol       Date:  2022-03-24       Impact factor: 2.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.